Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting
May 15, 2024 08:30 ET | Imunon, Inc.
LAWRENCEVILLE, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and...
Woman’s Hospital and Mary Bird Perkins – Our Lady of the Lake Cancer Center Open Breast and GYN Cancer Pavilion
April 30, 2018 11:59 ET | Woman's Hospital
Baton Rouge, La., April 30, 2018 (GLOBE NEWSWIRE) -- Women facing breast or gynecologic cancer will have increased access to specialized care in a unique facility specially built for women when the...